BlackRock’s Cogent Biosciences COGT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$61.9M Buy
8,626,581
+451,054
+6% +$3.24M ﹤0.01% 2300
2025
Q1
$49M Sell
8,175,527
-163,695
-2% -$981K ﹤0.01% 2361
2024
Q4
$65M Buy
8,339,222
+347,635
+4% +$2.71M ﹤0.01% 2275
2024
Q3
$86.3M Buy
7,991,587
+703,209
+10% +$7.59M ﹤0.01% 2146
2024
Q2
$61.4M Buy
7,288,378
+598,760
+9% +$5.05M ﹤0.01% 2269
2024
Q1
$45M Sell
6,689,618
-65,966
-1% -$443K ﹤0.01% 2450
2023
Q4
$39.7M Buy
6,755,584
+608,506
+10% +$3.58M ﹤0.01% 2579
2023
Q3
$59.9M Buy
6,147,078
+669,416
+12% +$6.53M ﹤0.01% 2270
2023
Q2
$64.9M Buy
5,477,662
+435,592
+9% +$5.16M ﹤0.01% 2287
2023
Q1
$54.4M Buy
5,042,070
+95,627
+2% +$1.03M ﹤0.01% 2352
2022
Q4
$57.2M Buy
4,946,443
+350,140
+8% +$4.05M ﹤0.01% 2344
2022
Q3
$68.6M Buy
4,596,303
+1,299,523
+39% +$19.4M ﹤0.01% 2200
2022
Q2
$29.7M Buy
3,296,780
+657,409
+25% +$5.93M ﹤0.01% 2811
2022
Q1
$19.8M Sell
2,639,371
-59,283
-2% -$444K ﹤0.01% 3113
2021
Q4
$23.2M Sell
2,698,654
-33,581
-1% -$288K ﹤0.01% 3126
2021
Q3
$23M Buy
2,732,235
+54,847
+2% +$461K ﹤0.01% 3139
2021
Q2
$21.7M Buy
2,677,388
+2,109,352
+371% +$17.1M ﹤0.01% 3193
2021
Q1
$4.99M Sell
568,036
-22,093
-4% -$194K ﹤0.01% 3881
2020
Q4
$6.63M Buy
590,129
+500,038
+555% +$5.62M ﹤0.01% 3503
2020
Q3
$843K Sell
90,091
-17,057
-16% -$160K ﹤0.01% 4052
2020
Q2
$197K Sell
107,148
-10,136
-9% -$18.6K ﹤0.01% 4286
2020
Q1
$194K Sell
117,284
-5,688
-5% -$9.41K ﹤0.01% 4163
2019
Q4
$355K Sell
122,972
-36,819
-23% -$106K ﹤0.01% 4162
2019
Q3
$920K Sell
159,791
-3,659
-2% -$21.1K ﹤0.01% 3957
2019
Q2
$1.71M Sell
163,450
-210,153
-56% -$2.2M ﹤0.01% 3775
2019
Q1
$6.56M Sell
373,603
-9,002
-2% -$158K ﹤0.01% 3285
2018
Q4
$6.73M Buy
382,605
+282,316
+282% +$4.97M ﹤0.01% 3265
2018
Q3
$4.13M Sell
100,289
-11,271
-10% -$464K ﹤0.01% 3511
2018
Q2
$6.4M Buy
+111,560
New +$6.4M ﹤0.01% 3400